Volume 25, Number 7—July 2019
Dispatch
Respiratory Syncytial Virus Infection in Homeless Populations, Washington, USA
Jim Boonyaratanakornkit1
, Seda Ekici1, Amalia Magaret, Kathryn Gustafson, Emily Scott, Micaela Haglund, Jane Kuypers, Ronald Pergamit, John Lynch, and Helen Y. Chu
, Seda Ekici1, Amalia Magaret, Kathryn Gustafson, Emily Scott, Micaela Haglund, Jane Kuypers, Ronald Pergamit, John Lynch, and Helen Y. Chu
Table 2
Clinical characteristics of patients admitted with RSV infection or influenza, Washington, USA, 2012–2017*
| Characteristic | RSV, n = 158 | Influenza, n = 712 | Univariable p value |
|---|---|---|---|
| Mean length of hospital stay, d | 5.5 | 4.6 | 0.67 |
| ICU admission | 39 (25) | 123 (17) | 0.041 |
| Mean length of ICU stay, d | 3.5 | 3.6 | 0.86 |
| Readmission within 30 d | 40 (25) | 79 (11) | <0.001 |
| Patients fitting SIRS criteria at admission | 78 (49) | 309 (43) | 0.18 |
| Antimicrobial drugs used† | 84 (53) | 224 (31) | <0.001 |
| Steroids used | 22 (14) | 61 (9) | 0.05 |
| Deaths | 7 (4) | 21 (3) | 0.61 |
*Values are no. (%) unless otherwise noted. Four patients were admitted twice with influenza, and 1 patient was admitted twice with RSV infection. ICU, intensive care unit; RSV, respiratory syncytial virus; SIRS, systemic inflammatory response syndrome.
†Included vancomycin, ceftriaxone, meropenem, azithromycin, levofloxacin, ciprofloxacin, amoxicillin, piperacillin/tazobactam, or ampicillin.
1These authors contributed equally to this article.
Page created: June 17, 2019
Page updated: June 17, 2019
Page reviewed: June 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.